Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians
(2019)
Journal Article
Fallowfield, L., Solis-Trapala, I., Starkings, R., Catt, S., May, S., & Jenkins, V. (2019). Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians. Breast Cancer Research and Treatment, 177, 641-649. https://doi.org/10.1007/s10549-019-05316-7
Purpose: Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemotherapy in ER positive, HER2 negative, early stage breast cancer. As health literacy and numeracy skills in the general population... Read More about Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians.